Author

Lionel Larbanoix

University of MonsORCID 0000-0001-6375-1133Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Abdulkader AzouziD· 1 shared Audrey PenningiD· 1 shared Bouchra Hassabi· 1 shared Céline Hubert· 1 shared Chengqi YiiD· 1 shared Emilie CalonneiD· 1 shared Évelyne CollignoniD· 1 shared Fabienne AndrisiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Abdulkader AzouzORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

TCR Signal Strength and Eomes Coordinate CD8⁺ T Cell Fate and Antitumor Immunity in Hepatocellular Carcinoma

Hacene Dreidi, Abdulkader Azouz, Sébastien Denanglaire, Solange Dejolier, Faustine Bouffioux, Marie Le Moine, Soren Temara, Lune Cassart, Muriel Nguyen, Lionel Larbanoix, Stanislas Goriely, Fabienne Andris

This study shows that TCR signal strength and Eomes determine CD8+ T cell fate in HCC, with high-affinity signals promoting antitumor immunity and Eomes driving exhaustion.

bioRxiv · Feb 12, 2026 · PreprintImmunology

m3C is a mitochondrial mRNA modification which promotes tumor progression

Audrey Penning, Kun Wang, Margot Celerier, Évelyne Collignon, Irina Primac, Louis Van der Linden, Martin Bizet, Emilie Calonne, Bouchra Hassabi, Céline Hubert, Pascale Putmans, Frédéric Murisier, Lionel Larbanoix, Younès Achouri, Jie Lan, , François Fuks

This study identifies m3C as a novel mitochondrial mRNA modification catalyzed by METTL8, which promotes tumor progression by enhancing complex I activity and oncogenic pathways.

bioRxiv · Jan 15, 2025 · PreprintCell Biology